Cocrystal Pharma, Inc.
(NASDAQ : COCP)

( )
COCP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -0.06%172.191.9%$283.52m
TEVATeva Pharmaceutical Industries Ltd. 0.47%10.622.0%$95.87m
COCPCocrystal Pharma, Inc. 1.77%1.150.0%$45.97m
JAGXJaguar Health, Inc. 1.58%1.290.9%$11.49m
RDYDr. Reddy's Laboratories Ltd. 0.00%72.002.0%$10.62m
TXMDTherapeuticsMD, Inc. -0.95%1.0415.3%$9.03m
ABEOAbeona Therapeutics, Inc. -2.17%1.353.8%$2.59m
TAROTaro Pharmaceutical Industries Ltd. -1.30%72.996.5%$1.58m
KINKindred Biosciences, Inc. 0.00%4.350.2%$1.22m
LFVNLifeVantage Corp. 0.00%8.153.4%$0.90m
CPHIChina Pharma Holdings, Inc. 2.44%0.600.1%$0.36m

Company Profile

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.